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Epigenetic modulation is critical for regulating the development and function of T cells. In this issue of
Immunity, DuPage et al. (2015) show that the chromatin-modifying enzyme Ezh2 induced by CD28 costi-
mulation is essential for regulatory T (Treg) cell maintenance during activation and differentiation.Regulatory T (Treg) cells are a specialized
T cell subset critical for immune mainte-
nance and homeostasis and considered
to be the guardian of life. It is well estab-
lished that the transcription factor Foxp3
defines the functions of Treg cells. T cell
receptor (TCR), costimulatory, and cyto-
kine signals, however, are also critical
for their development. Here DuPage
et al. suggest that CD28 signals induce
the chromatin-remodeling enzyme Ezh2
during the Treg cell development, which
regulates Treg cell activation and function
(DuPage et al., 2015).
Ezh2, the histone methyltransferase of
multi-subunit polycomb repressive com-
plex 2 (PRC2), is an essential epigenetic
regulator of development of multiple cell
types in mice and functions as a key fac-
tor for regulating histone H3 methylation
of lysine 27 (H3K27me3) in both B cells
and T cells (O’Carroll et al., 2001; Su
et al., 2003). During normal development
of Tregs cells, the position and frequency
of H3K27me3 across the span of genes
within Treg cells is different compared
with other T cell subsets. Ezh2 is re-
cruited by Foxp3 during Treg cell devel-
opment and not only controls Foxp3
expression (Arvey et al., 2014) but also
genomic landscape as reported in the
study highlighted here (DuPage et al.,
2015).
By performing cDNA transcript analysis
on human naive CD4+ T cells co-stimu-
lated in the presence of CD28, the
authors showed that Ezh2 was the most
highly expressed gene among different
chromatin modifiers. The induction of
Ezh2 by CD28 co-stimulation was further
confirmed in murine Treg cells, which
correlated with Ezh2 enzymatic activity
and abundance of H3K27me3 histone
marks. Furthermore, higher amounts
of Ezh2 expression and H3K27me3were observed in the activated Treg cell
compartment defined by expression
of CD44 and CD62L (CD44+CD62L),
versus the resting CD44CD62L+ Treg
cells, suggesting that the expression
of Ezh2 coordinates Treg cell activa-
tion and potentially regulates Treg cell
functions.
By generating Ezh2 Treg cell-specific
deficient (Treg.Ezh2D/D) mice, the authors
observed enhanced frequency of Treg
cells in lymph nodes and thymus, along
with higher expression of surface proteins
such as CTLA-4, PD-1, CD103, and GITR
on the Tregs of the aged Treg.Ezh2D/D
mice. However, the in vitro analysis of
Treg cells from the Treg.Ezh2D/D mice
did not show enhanced Treg cell suppres-
sive capacity in CD62Lhi cells.
In contrast to the in vitro data, further
in vivo investigation on the Treg.Ezh2D/D
mice showed that there was a higher
frequency of activated CD4+ and CD8+
T cells, together with enhanced lymph
node cellularity. More importantly, the
Treg.Ezh2D/D mice developed systemic
autoimmune and inflammatory pheno-
type, which was caused by massive lym-
phocytic infiltration. To further address
whether it is a cell intrinsic effect of
Ezh2, the authors introduced Foxp3Yfp-cre
knockin allele to the female Ezh2fl/fl
mice. Due to random X-inactivation,
the same amount of normal and Ezh2-
deficient Treg cells could be found in
the Foxp3Yfp-cre/WT Ezh2fl/fl mice. Under
such settings, these mice exhibited
normal immune status as the wild-type
(WT) mice, suggesting the WT Treg
(Ezh2fl/fl) cells overcame the deficiency
of losing Ezh2 (Treg.Ezh2D/D) in the Treg
cells. Then the authors refined the ex-
periments by introducing the Foxp3DTR
allele together with the Foxp3Yfp-cre allele
into the Ezh2fl/fl mice (Foxp3Yfp-cre/DTRImmunity 42,Ezh2fl/fl). In this way, the Treg cells
carrying diphtheria toxin receptor (DTR)
with WT phenotype could be deleted by
diphtheria toxin (DT) treatment so that
the immediate effect of immune regu-
lation in the mice could be controlled
by the Ezh2-deficient Treg cells that re-
mained in the repertoire. Indeed, after
WT Treg cell depletion, these mice devel-
oped similar pathological symptoms as
Treg.Ezh2D/D mice.
The authors then analyzed Treg cells
in non-lymphoid tissues including skin,
lung, liver, and pancreas. The reduction
of Foxp3+ Ezh2-deficient Treg cells was
seen in all of these tissues. The authors
then utilized the Foxp3 fate-mapping
mouse as previously reported (Komatsu
et al., 2014). Using this strategy, the
Treg.Ezh2D/D mice were first observed
to have more newly generated Treg
(CD4+GFP+RFP) cells originated from
the thymus compared to the controls.
More importantly, these mice exhibited
an increased frequency of ‘‘Ex-Treg’’
(CD4+GFPRFP+) cells within all tissues,
particularly in non-lymphoid tissues.
Interestingly, all the Ex-Treg cells were
found to display the activated phenotype
(CD44+CD62L), indicating the critical
role of Ezh2 for both activation and
stability of Treg cells.
In order to understand the molecular
mechanism by which Ezh2 regulates
Treg cell functions, DuPage et al. per-
formed RNA-seq by employing a sophis-
ticated sorting strategy. They isolated
different cell populations including
CD62L+ or CD62L Ezh2D/D and control
Treg cells from Foxp3Yfp-cre/WT; Ezh2fl/+
or Foxp3Yfp-cre/WT; Ezh2fl/fl mice. Between
the WT and Ezh2-deficient Treg cells, the
most gene-expression differences were
found within the activated (CD62L) Treg
cell populations. The genes that wereFebruary 17, 2015 ª2015 Elsevier Inc. 201
Figure 1. Ezh2 Regulates Function and Stability of Treg Cells
(Top)Within activated (CD44+)WT Treg cells, CD28 signal enhances the expression of Ezh2, leading to the
deposition of genomic H3K27me3 and the repression of transcription of genes that inhibit Treg cell devel-
opment. Induction of Ezh2 maintains the expression of Foxp3 and stabilizes the identity of Treg cells
(shown in yellow). Therefore, the WT Treg cells exert strong suppressive function even in the face of
tissue inflammation and during autoimmune reaction in EAE.
(Bottom) In contrast to WT Treg cells, the Ezh2-deficient activated Treg cells fail to promote the repressive
gene program for Treg cell development and display a more activated phenotype (CD44+). Therefore, the
Ezh2-deficient mice develop more systemic autoimmune reactions with more ‘‘Ex-Treg’’ cells (shown in
red), which lose Foxp3 expression and have no suppressive function. The mice show a defect in Treg
cell function and massive infiltration of effector and Ex-Tregs in multiple organs. Finally, the absence of
Ezh2 within Treg cells leads to the development of more severe EAE compared to WT mice, and the
Treg cells lose their identity and function.
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cells were found to be repressed in
CD62L T cells. These genes were asso-
ciated with a decrease in H3K27me3 level
by cross-referencing the RNA-seq data
with the previous dataset by Arvey et al.
(2014). Furthermore, the comparison
between the Ezh2-deficient and Foxp3-
deficient Treg cells revealed an overlap
of differentially expressed genes (DEG)
within the CD62L cell compartment.
These data suggest that the Ezh2-medi-
ated H3K27me3 is not only important for
Foxp3-dependent Treg cell program but
also for maintaining Treg cell activation
program.
Finally, the authors tested the impact of
loss of Ezh2 in Treg cells in vivo using a
murine model of experimental auto-
immune encephalomyelitis (EAE). Tre-
g.Ezh2D/D mice developed more severe
disease than the control mice with reduc-
tion in the frequency of Treg cells in the
central nervous system (CNS). The Ezh2-
deficient Treg cells could not control the202 Immunity 42, February 17, 2015 ª2015 Edisease because of decreased stability
of Foxp3, consistent with the data in the
naive mice. Employing the antigen tetra-
mers further showed less antigen-specific
Treg cells in the absence of Ezh2 within
the CNS at the peak of the disease
(Figure 1).
This study provides detailed character-
ization and comprehensive analysis of
the effect on loss of an enzyme Ezh2 in
Treg cell maintenance and function, using
both in vitro and in vivo functional assays,
genomic computational analysis, and
autoimmune disease models to analyze
the impact of the Ezh2 enzyme on the
development of Treg cells. The authors
demonstrated that Ezh2, as an epigenetic
modifier, is a key factor required in Treg
cell activation and stabilization. The paper
links Treg cell induction by CD28 costimu-
lation with chromatin modification, which
reconciles the old data showing a critical
role of CD28 costimulation in the genera-
tion and function of Foxp3+ Treg cells
(Tang et al., 2003).lsevier Inc.Activated Treg cells, which are induced
in the peripheral or secondary lymphoid
organs, are found to have enhanced abil-
ity to migrate and mediate suppression.
In comparison to the resting Treg cells,
activated Treg cells show distinct surface
markers, chemokine receptors, gene ex-
pression, and epigenetic modifications,
although Foxp3 expression is essential
in the maintenance of both resting and
activated Treg cells. As reported by
DuPage et al., the deficiency of Ezh2
destabilized Treg cells only in the acti-
vated pool, suggesting the dynamic
epigenetic regulation in Treg cells, during
activation and in various microenviron-
ments. Moreover, Treg cells change their
phenotype and function in different in-
flammatory conditions and tissue envi-
ronments and become specialized to
mediate their specific effector in defined
tissues (Burzyn et al., 2013; Cipolletta
et al., 2012). The requirement of Ezh2
in Treg cell populations in non-lymphoid
tissues suggests that Ezh2 might also
play an important role in inducing
genomic and transcriptional changes in
tissue Tregs. In addition, Treg cells
were also found to be inactivated during
acute inflammation (Fontenot et al.,
2005). This study raises an interesting
issue of whether Treg cell destabilization
observed at the sites of acute inflam-
mation is due to downregulation or inacti-
vation of Ezh2 by certain tissue cues and
inflammatory stimuli.
The function of Ezh2 has been well
characterized in cancer. Either hyperacti-
vation or mutations are found in a variety
of malignancies (Simon and Lange,
2008). Ezh2was now shown to participate
in the regulation of Treg cell activation and
T helper 1 (Th1) and Th2 cell differentia-
tion. Thus, it is worthwhile to study the
application of several potent Ezh2 inhibi-
tors developed in the research of cancer
for the treatment of autoimmune dis-
eases. The predominant role of Ezh2 in
many cell types implicates a common
mechanism of regulation of H3K27me3
status, due to activation or costimulation,
in coordination of gene expression and
cell function.REFERENCES
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Downstream of costimulatory pathways, complexes of transcription factors NFAT and AP-1 promote effector
T cell differentiation. In this issue of Immunity, Martinez et al. report that monomeric NFAT binding in the
absence of a transcriptional partner induces a gene expression program involved in T cell exhaustion.T cell exhaustion is a type of T cell
dysfunction that occurs in many chronic
infections and cancer. Hallmarks of T cell
exhaustion include reduced effector func-
tion, expression of inhibitory receptors
(e.g., programmed cell death-1 [PD-1]),
and distinct transcriptional and metabolic
states. Recently, checkpoint blockade
targeting inhibitory receptors expressed
by exhausted T (Tex) cells such as PD-1
has shown great promise in patients with
advanced cancer. In contrast to effector
T (Tef) cells generated in the presence of
adequate T cell receptor (TCR) stimulation
and costimulation, Tex cells arise in the
context of high and prolonged antigen
stimulation and excess of coinhibitory
over costimulatory signals. However, our
understanding of how T cells integrate
this information into the transcription of
‘‘exhaustion’’ versus ‘‘effector’’ gene pro-
grams remains limited.
Several transcriptional circuits have
been implicated in Tex cells including tran-
scription factors T-bet and Eomes, Blimp-
1, hypoxia-inducible factors, Foxo1, the
AP-1 family member BATF, and NFAT
(Kahan et al., 2015). Some transcriptionfactors like BATF might regulate early
TCR-dependent expression of other tran-
scription factors shared between Tex
and Tef cells. Other transcriptional circuits
have been described in Tex versus func-
tional T cells. Transcriptional network
analysis highlighted the context-depen-
dent nature of key transcription factors ex-
pressed by Tex cells, indicating that these
transcription factors can be linked to dif-
ferential gene expression in Tex compared
to functional T cells (Doering et al.,
2012). For example, quantitative changes
in T-box transcription factors (e.g., T-bet,
Eomes) are associated with exhaustion
compared to memory development.
Despite this work it remains unclear what
the earliest transcriptional control points
are that govern the development of func-
tional versus dysfunctional T cells.
In this issue of Immunity, Martinez et al.
(2015) show that different modes of tran-
scription factor NFAT binding underlie the
expression of exhausted versus effector
transcriptional programs (Figure 1). Lym-
phocytes express NFAT family members
1, 2, and 4 that get activated by TCR-
induced, calcium-dependent, calcineurin-mediated dephosphorylation of cytosolic
NFAT and subsequent nuclear transloca-
tion. In addition to a DNA binding domain,
NFATs contain domains that allow pro-
tein-protein interactions with other tran-
scriptional cofactors. Such a system al-
lows integration of transcriptional inputs
downstream of costimulatory and other
regulatory signals. For example, in Tef
cells, binding of AP-1 complexes formed
downstream of costimulatory signaling
pathways is critical for transcription of
T cell effector proteins, such as inter-
leukin-2 (IL-2) and interferon-g (IFN-g).
Importantly, lack of transcriptional coop-
eration between NFAT and other tran-
scription factors is involved in T cell
anergy, a distinct type of dysfunctional
T cells that contributes to peripheral toler-
ance (Mu¨ller and Rao, 2010). Anergic
CD4+ T cells are induced by TCR engage-
ment without costimulation, a scenario
that activates NFAT in the absence of
AP-1 and initiates transcription of anergy-
related genes. A different regulatory
mechanism involving NFAT occurs in
regulatory T cells, where NFAT co-binding
with FOXP3 results in transcriptionalFebruary 17, 2015 ª2015 Elsevier Inc. 203
